RxDoctor Payments Data

Brian Gladnick, MD

Orthopaedic Surgery · Dallas, TXNPI 1184949505

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $120,701 of the $141,493 with a category attached, or 85.3%. 16 manufacturers reported payments, led by Medical Device Business Services, Inc. at 52.5% of the total. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$141,493in general payments, 2019–2025

Across 165 payments — averaging $857.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$74K
  • Encore Medical, LP$35K
  • Depuy Synthes Products, Inc.$23K
  • Zimmer Biomet$3K
  • Synthes GmbH$2K
  • Insight Medical Systems, Inc.$1K
  • plus $2K from 10 others
$73,642in research payments, 2019–2025

Across 13 payments — averaging $5664.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$74K

What the payments were for

  • Consulting fees$120,70185%
  • Speaking & faculty fees$1,5001%
  • Travel & lodging$15,47311%
  • Food & beverage$3,8193%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$141,493 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$510,527
Medicare patients
880
Services billed
4,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen246$2,186
Cefadroxil163$1,149
Cephalexin373$794
Ibuprofen126$754
Mupirocin107$688
Diclofenac Sodium71$683
Methylprednisolone112$579
Celecoxib16$155
Tramadol Hcl38$121
Methocarbamol13$68
Meloxicam15$31
Clindamycin Hcl17$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →